logo
搜索
菜单

Pre-clinic的搜索结果

当前1/3页
排序: 总浏览数
In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum 10.3791/1210-v
In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum
Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies 10.3791/50036-v
Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Assessing Functional Performance in the Mdx Mouse Model 10.3791/51303-v 10:32 min
Assessing Functional Performance in the Mdx Mouse Model
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression 10.3791/50395-v 09:25 min
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System 10.3791/52554-v
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic 10.3791/4030-v 08:51 min
Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia 10.3791/50720-v 10:49 min
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens 10.3791/2846-v
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System 10.3791/3956-v
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields) 10.3791/55820-v
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells 10.3791/58492-v
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer 10.3791/54125-v 07:01 min
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
A Murine Model of Cervical Spinal Cord Injury to Study Post-lesional Respiratory Neuroplasticity 10.3791/51235-v 09:09 min
A Murine Model of Cervical Spinal Cord Injury to Study Post-lesional Respiratory Neuroplasticity
Development of an Alpha-synuclein Based Rat Model for Parkinson’s Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector 10.3791/53670-v 08:33 min
Development of an Alpha-synuclein Based Rat Model for Parkinson’s Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Intratracheal Administration of Dry Powder Formulation in Mice 10.3791/61469-v 07:55 min
Intratracheal Administration of Dry Powder Formulation in Mice
Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices 10.3791/61036-v 08:27 min
Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring 10.3791/52757-v 07:35 min
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder 10.3791/55864-v 07:51 min
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Use of Frozen Tissue in the Comet Assay for the Evaluation of DNA Damage 10.3791/59955-v 11:30 min
Use of Frozen Tissue in the Comet Assay for the Evaluation of DNA Damage
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds 10.3791/53885-v 13:34 min
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
返回顶部